Description
Phase
Phase 3 - a treatment has shown activity against a particular disease, where it is either added to existing treatment or compared to the standard treatment.Inclusion and Exclusion Criteria
Please contact the trial administrator to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
California
- University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California, 90033
- University of Southern California, Keck School of Medicine, Los Angeles, California, 90033
- Lotus Clinical Research, LLC, Pasadna, California, 91105
- Vascular Interventional Specialists of Orange County, Orange, California, 92868
-
Nevada
- William Muir MD Spine Surgery, Las Vegas, Nevada, 89144
-
Utah
- Physician's Research Options, Sandy, Utah, 84070
-
Colorado
- Spine Colorado, Durango, Colorado, 81303
- Boulder Neurological Institute, Boulder, Colorado, 80304
-
Washington
- Multicare Neuroscience Center of Washington, Tacoma, Washington, 98405
- Northwest Orthopaedic Specialists, P.S., Spokane, Washington, 99208
- Overlake Hospital Medical Center, Bellevue, Washington, 98004
- Virginia Mason Medical Center, Seattle, Washington, 98101
-
Texas
- University of North Texas Health Sciences Center, Fort Worth, Texas, 76107
-
Oklahoma
- The University of Oklahoma - Tulsa, Tulsa, Oklahoma, 74135
-
Missouri
- Washington University School of Medicine, St. Louis, Missouri, 63110
-
Illinois
- Southern Illinois University School of Medicine, Springfield, Illinois, 62702
- NorthShore University HealthSystem, Skokie, Illinois, 60077
- Northwestern University, Chicago, Illinois, 60611
-
Alabama
- University of Alabama at Birmingham, Birmingham, Alabama, 35233
- Cardio-Thoracic Surgeons, PC, Birmingham, Alabama, 35242
-
Indiana
- Indiana Spine Group, Carmel, Indiana, 46032
-
Michigan
- Borgess Research Institute, Kalamazoo, Michigan, 49048
-
Kentucky
- Bluegrass Orthopedics, Lexington, Kentucky, 40509
Powered by
SC CTSI